STAT Plus: U.S. Patent Office removes lawyer from high-profile case involving a Gilead HIV medicine
The U.S. Patent and Trademark Office has removed a senior legal adviser from a high-profile case after she tweeted contentious remarks about the right of AIDS activists to challenge a patent-term extension sought by Gilead Sciences (GILD) for an HIV medicine.
A spokesman for the federal agency told us that Mary Till, a 14-year employee who reviews extension requests, is “no longer working on the matter.”
Continue to STAT Plus to read the full story…
